Zymogenetics, the Seattle-based pharmaceutical company owned by Bristol-Myers Squibb, will start the process of laying off workers and closing its… Read More
Secretive biotechnology company Receptor Life Sciences has raised a funding round totaling just over $7.5 million, according to a filing with… Read More
Nine years after he underwent treatment for non-Hodgkin’s lymphoma, a potentially fatal but treatable form of cancer, Microsoft co-founder Paul… Read More
Seattle-based biotech company Adaptive Biotechnologies announced Friday that the FDA has cleared its clonoSEQ platform for use. It marks first time a technology… Read More